Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06597058
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-11
Brief Title:
Phase 2b Efficacy and Safety Study of Fixed Dose Drugs Combination Type of Polypill
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Double-Blind Placebo-Controlled Phase 2b Efficacy and Safety Study of Fixed Dose Drugs Combination Type of Polypill Administered to Subjects with Alzheimers Disease
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to assess the clinical response to a drug combination type of polypill in patients with AD after 180 days of treatment The anticipated study population are males and females aged 50-85 years with mild to severe Alzheimers Disease The duration of individual patient participation will be approximately 224 Days up to 14 days for Screening 180 days for study drug administration and a final follow-up visit at 210 days The planned study duration is 12-18 months from Screening of the first patient until the last follow-up of the last patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None